Company Performance - Lifan Pharmaceutical's stock price reached a historical high, increasing by 6.45% to 35.81 yuan, with a trading volume of 2.0682 million shares and a transaction value of 73.2369 million yuan, resulting in a turnover rate of 1.50% [2] - The company's latest A-share total market capitalization is 6.81 billion yuan, with a circulating market capitalization of 4.932 billion yuan [2] Industry Overview - The pharmaceutical and biotechnology industry has an overall increase of 0.50%, with 300 stocks rising, including notable gainers such as Furuide Co., Norsland, and Jimin Health, which saw increases of 18.46%, 10.98%, and 10.00% respectively [2] - Conversely, 176 stocks in the industry experienced declines, with the largest drops seen in Guangyuyuan, Haochen Medical, and Meihao Medical, which fell by 5.19%, 4.01%, and 3.45% respectively [2] Financial Results - In the first quarter, the company reported a total revenue of 360 million yuan, reflecting a year-on-year growth of 7.98% [2] - The net profit for the same period was 38.2503 million yuan, representing a year-on-year increase of 25.94%, with basic earnings per share of 0.2000 yuan and a weighted average return on equity of 2.18% [2]
立方制药涨6.45%,股价创历史新高